Good Numbers From Genentech

Genentech reported very good numbers after the market close. They generated revenues of $1.75 billion and earnings per share of $0.35, which beat analyst estimates. Investors are pleased with the numbers and the stock is trading up 5% in after hours. Amgen and Genzyme will report next week and both should deliver solid numbers as well.

The cnnfn web site had a nice chart comparing the p/e and eps growth rate for some of the biotech and pharma companies. Pricey, but worth it? My answer is YES!